CardioFocus has announced late-breaking data and an expansion of its pulsed field ablation clinical programs. The company has also reported on various clinical trials and evaluations, including those involving its HeartLight Excalibur Balloon, QuickShot Nav Large Area Focal PFA Catheter, and CardioWave PFA System. The specific outcomes and details of these announcements are not consistent across reports, suggesting that multiple developments are being shared by the company.